Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients
about
Fitting and interpreting continuous-time latent Markov models for panel dataEarly extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation.Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipientsThe presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome.Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allograftsLongitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation.Scintigraphy at 3 months after single lung transplantation and observations of primary graft dysfunction and lung function.Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.Update in transplantation 2007.A review of bronchiolitis obliterans syndrome and therapeutic strategies.Chronic lung allograft dysfunction after lung transplantation: the moving target.Pediatric lung transplantation: promise being realized.Improving survival outcomes in lung transplant recipients through early detection of bronchiolitis obliterans: Daily home spirometry versus standard pulmonary function testing.Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung Transplantation.[Chronic rejection: Differences and similarities in various solid organ transplants].Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation.Parametric Response Mapping as an Imaging Biomarker in Lung Transplant Recipients.Lung Transplantation
P2860
Q30641833-035847EF-4B6A-478E-B549-8F484BAFADD8Q33622446-2CA20193-4A0A-4D14-9F43-0ABEA4CF46A8Q33788054-620DC1BA-99EF-4C59-B896-409E711F98E2Q34172126-8B60434C-824C-494A-B58C-D564673CA85FQ34447908-B1FD3F28-0819-45C1-9ACF-912794CF1B8FQ34914577-BEAE9A0E-FFB8-408D-B33B-BFB2029C82F8Q35683015-D05DFCBE-5301-4A17-8C18-9DE83F3647F3Q35941658-A0BD1722-F4DF-42C3-BC13-846113FEEA67Q35961856-196E1655-E7D4-4E91-A0F8-8D7005D26FEFQ36547137-C2AB5ED9-60D4-41DF-BFF4-09C7A0B27480Q36623201-EDF46C8B-A363-42F8-9D60-784EE257FD7DQ37156062-A381755C-56D5-48FE-B8DC-B0AD07BAE270Q37902258-5D42C29D-25CD-4A30-9D45-B6D4347D4B01Q38058746-70E34355-4FC6-4F06-84F0-F6C3631F3461Q38204614-A17637A3-CA2A-47F5-93DF-7630754F746AQ38528862-AA87582F-7886-4C6F-9056-A5D83ED67A3AQ38645350-CBC63E58-6EEC-4B9C-9E5F-82F0A327FC3AQ40967497-C5E621BB-1572-44DD-8A41-74378043E59CQ42768766-A0F31F8C-DFF4-4735-91B5-48A39CA551FFQ44793703-574245DE-F171-45CD-AF29-0BE05DD702F7Q46959319-654C30FE-E7E5-418C-A1C4-932EC1011027Q51751594-9406E6F4-C8B4-4243-B95F-9D1FB7FF1035Q56505206-49A4C68B-C6C1-4F1E-93AF-71932813D323
P2860
Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Course of FEV(1) after onset o ...... in lung transplant recipients
@ast
Course of FEV(1) after onset o ...... in lung transplant recipients
@en
Course of FEV(1) after onset o ...... in lung transplant recipients
@nl
type
label
Course of FEV(1) after onset o ...... in lung transplant recipients
@ast
Course of FEV(1) after onset o ...... in lung transplant recipients
@en
Course of FEV(1) after onset o ...... in lung transplant recipients
@nl
prefLabel
Course of FEV(1) after onset o ...... in lung transplant recipients
@ast
Course of FEV(1) after onset o ...... in lung transplant recipients
@en
Course of FEV(1) after onset o ...... in lung transplant recipients
@nl
P2093
P2860
P1476
Course of FEV(1) after onset o ...... in lung transplant recipients
@en
P2093
Andrew Flint
Christine Lau
Fernando J Martinez
Galen B Toews
Kevin M Chan
Robert J Lonigro
Vibha N Lama
P2860
P304
P356
10.1164/RCCM.200609-1344OC
P407
P577
2007-03-08T00:00:00Z